Why did these brokers upgrade the Evolution Mining share price to buy?

The investment debate on ASX gold shares continues.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Despite a recent pullback in its share price and the price of gold struggling in 2022, brokers are still turning constructive on Evolution Mining
  • Not all are bullish however, as many are still happy waiting on the sidelines for now
  • In the last 12 months the Evolution Mining share price has slipped more than 29% into the red

Shares of Evolution Mining Ltd (ASX: EVN) have jumped from the open and now trade around 1% higher at $3.73 apiece.

Zooming out for a wider view, however, Evolution has struggled in 2022 having clipped an 8% loss this year to date. Over the last month of trade, shares are down 8% as well.

Meanwhile, the price of gold has also taken a backward step this past month, dipping almost 1% into the red to bring a year-on-year loss of more than 3%.

Two miners examine things they have taken out the ground.

Image source: Getty Images

Broker upgrades for Evolution Mining

Analysts at JP Morgan upgraded their rating on Evolution Mining in a recent note, bringing their rating to overweight.

"We remain attracted to gold stocks on a 1y view and believe the recent pullback in stock prices provides a good entry point amongst a supportive macro backdrop," the broker said in a recent note.

The broker is attracted to the company's Cowal, Red Lake and Ernest Henry assets and also mentioned that Evolution had a good track record on its acquisition front.

We upgrade Evolution to overweight, and it is now our top pick from a valuation perspective, trading on a P/NPV of 0.77x and offering a 10% 5 year CAGR [compound annual growth rate] in production and a 3.2% FY23 estimated dividend yield.

JP Morgan values Evolution Mining at $4.80 per share, in line with Shaw and Partners on a $4.75 per share valuation.

Meanwhile, analysts Yi Zhu and Anthony Cham Fung Yau at Bloomberg Intelligence reckon Evolution's $1.4 billion capital expenditure (capex) should be accretive to the company's earnings. They wrote:

Evolution's A$1.4 billion capex should improve productivity at its recently-acquired assets, lifting production by 320,000 ounces at lower unit costs.

Investments include brownfield exploration, new mine plans and extraction of synergies. This strategy has previously served the company well and we expect similar results with the most recent additions.

Not all recommend a buy

While 25% of coverage advocates buying Evolution Mining shares, around 44% of brokers still say the company is a hold, and 31% recommend investors sell, according to Bloomberg data.

Both Credit Suisse and Macquarie downgraded their ratings to underperform yesterday, valuing the company at $3.75 and $4 per share respectively.

RBC Capital and Barrenjoey Markets also rate Evolution a sell in separate notes from April.

The consensus price target is still $4.34 per share from this list, suggesting around 16% upside potential at the time of writing.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »